Podcasts about Clinical research

Host: Brian P. McDonough, MD, FAAFP Guest: Tara Graff, DO, MS Guest: Surbhi Sidana, MD While BCMA-directed CAR T-cell therapy has changed the treatment landscape for patients with relapsed and refractory (R/R) multiple myeloma, access remains uneven outside academic centers. In this expert-led discussion, Dr. Brian McDonough, Dr. Surbhi Sidana, and Dr. Tara Graff explore real-world barriers to referral and delivery, evolving care models, and the multidisciplinary coordination required to extend CAR T therapy into community practice. Dr. Sidana is an Associate Professor of Medicine, and she leads the Myeloma CAR T and Immunotherapy program at Stanford Medicine. Dr. Graff is the Director of Clinical Research at Mission Cancer + Blood, and she serves on the National CAR T-Cell Advisory Board for Multiple Myeloma.

My substack FREE: https://substack.com/@dansfera1?r=27gh4e&utm_medium=ios&utm_source=profileInato: https://go.inato.com/3VnSro6CRIO: http://www.clinicalresearch.ioMy PatientACE recruitment company: https://patientace.com/Join me at my conference! http://www.saveoursites.comText Me: (949) 415-6256Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7aGET THE BOOK! https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1?keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorrText "guru" to 855-942-5288 to join VIP list!My blog: http://www.TheClinicalTrialsGuru.comMy CRO and Site Network: http://www.DSCScro.comMy CRA Academy: http://www.TheCRAacademy.comMy CRC Academy: http://www.TheCRCacademy.comLatinos In Clinical Research: http://www.LatinosinClinicalResearch.comThe University Of Clinical Research: https://www.theuniversityofclinicalresearch.com/My TikTok: DanSfera

Hannah's LinkedIn: https://www.linkedin.com/in/hannahkempski/My substack FREE: https://substack.com/@dansfera1?r=27gh4e&utm_medium=ios&utm_source=profileInato: https://go.inato.com/3VnSro6CRIO: http://www.clinicalresearch.ioMy PatientACE recruitment company: https://patientace.com/Join me at my conference! http://www.saveoursites.comText Me: (949) 415-6256Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7aGET THE BOOK! https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1?keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorrText "guru" to 855-942-5288 to join VIP list!My blog: http://www.TheClinicalTrialsGuru.comMy CRO and Site Network: http://www.DSCScro.comMy CRA Academy: http://www.TheCRAacademy.comMy CRC Academy: http://www.TheCRCacademy.comLatinos In Clinical Research: http://www.LatinosinClinicalResearch.comThe University Of Clinical Research: https://www.theuniversityofclinicalresearch.com/My TikTok: DanSfera

My substack FREE: https://substack.com/@dansfera1?r=27gh4e&utm_medium=ios&utm_source=profileInato: https://go.inato.com/3VnSro6CRIO: http://www.clinicalresearch.ioMy PatientACE recruitment company: https://patientace.com/Join me at my conference! http://www.saveoursites.comText Me: (949) 415-6256Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7aGET THE BOOK! https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1?keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorrText "guru" to 855-942-5288 to join VIP list!My blog: http://www.TheClinicalTrialsGuru.comMy CRO and Site Network: http://www.DSCScro.comMy CRA Academy: http://www.TheCRAacademy.comMy CRC Academy: http://www.TheCRCacademy.comLatinos In Clinical Research: http://www.LatinosinClinicalResearch.comThe University Of Clinical Research: https://www.theuniversityofclinicalresearch.com/My TikTok: DanSfera

Dr. Josh introduces his journey, clinical background, global summit, and the scientific evidence behind Alzheimer's prevention and reversal. #AlzheimersHope #ReversalEvidence #BrainHealth #NeuroWellness

Send us a textDo Heterogeneous Treatment Effects Exist?For the last 50 years, we've designed cars to be safe...For the 50th-percentile male.Well, that's actually not 100% correct.According to Stanford's report, we introduced "female" crash test dummies in the 1960s, but...They were just scaled-down versions of male dummies and...Represented the 5th percentile of females in terms of body size and mass (aka the smallest 5% of women in the general population).These dummies also did not take into account female-typical injury tolerance, biomechanics, spinal alignment, and more.But...Does it matter for actual safety?In the episode, we cover:- Do heterogeneous treatment effects (different effects in different contexts) exist?- If so, can we actually detect them?- Is it more ethical to look for heterogeneous treatment effects or rather look at global averages?Video version available on the Youtube: https://youtu.be/V801RQTBpp4Recorded on Nov 12, 2025 in Malaga, Spain.------------------------------------------------------------------------------------------------------About RichardProfessor Richard Hahn, PhD, is a professor of statistics at Arizona State University (ASU). He develops novel statistical methods for analyzing data arising from the social sciences, including psychology, economics, education, and business. His current focus revolves around causal inference using regression tree models, as well as foundational issues in Bayesian statistics.Connect with Richard:- Richard on LinkedIn: https://www.linkedin.com/in/richard-hahn-a1096050/About StephenStephen Senn, PhD, is a statistician and consultant who specializes in drug development clinical trials. He is a former Group Head at Ciba-Geigy and has taught at the University of Glasgow and University College London (UCL). He is the author of "Statistical Issues in Drug Development," "Crossover Trials in Clinical Research," and "Dicing with Death."Connect with Stephen:- Stephen on LinkedIn: Support the showCausal Bandits PodcastCausal AI || Causal Machine Learning || Causal Inference & DiscoveryWeb: https://causalbanditspodcast.comConnect on LinkedIn: https://www.linkedin.com/in/aleksandermolak/Join Causal Python Weekly: https://causalpython.io The Causal Book: https://amzn.to/3QhsRz4

My substack FREE: https://substack.com/@dansfera1?r=27gh4e&utm_medium=ios&utm_source=profileInato: https://go.inato.com/3VnSro6CRIO: http://www.clinicalresearch.ioMy PatientACE recruitment company: https://patientace.com/Join me at my conference! http://www.saveoursites.comText Me: (949) 415-6256Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7aGET THE BOOK! https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1?keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorrText "guru" to 855-942-5288 to join VIP list!My blog: http://www.TheClinicalTrialsGuru.comMy CRO and Site Network: http://www.DSCScro.comMy CRA Academy: http://www.TheCRAacademy.comMy CRC Academy: http://www.TheCRCacademy.comLatinos In Clinical Research: http://www.LatinosinClinicalResearch.comThe University Of Clinical Research: https://www.theuniversityofclinicalresearch.com/My TikTok: DanSfera

Dr. Chris Goss (Medicine, Pediatrics; Associate Dean for Clinical Research) discusses ways faculty can partner with industry to fund clinical research, serving their patients with cutting-edge science. Dr. Goss recommends working with your department and the UW Clinical Trials Office who can help with the entire study process including conversations with industry partners, IRB questions, and site-specific resources. He walks through the timeline and responsibilities involved with being a principal investigator in a clinical trial and provides tips for how to be successful amidst common bottlenecks and challenges. Clinical research at UW has grown significantly and may be an excellent pathway for faculty looking to diversify their research funding.Learn about the UW Clinical Trials Office here.Music by Kevin MacLeod (https://incompetech.com/)

My substack FREE: https://substack.com/@dansfera1?r=27gh4e&utm_medium=ios&utm_source=profileInato: https://go.inato.com/3VnSro6CRIO: http://www.clinicalresearch.ioMy PatientACE recruitment company: https://patientace.com/Join me at my conference! http://www.saveoursites.comText Me: (949) 415-6256Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7aGET THE BOOK! https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1?keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorrText "guru" to 855-942-5288 to join VIP list!My blog: http://www.TheClinicalTrialsGuru.comMy CRO and Site Network: http://www.DSCScro.comMy CRA Academy: http://www.TheCRAacademy.comMy CRC Academy: http://www.TheCRCacademy.comLatinos In Clinical Research: http://www.LatinosinClinicalResearch.comThe University Of Clinical Research: https://www.theuniversityofclinicalresearch.com/My TikTok: DanSfera

Jaime's LinkedIn: https://www.linkedin.com/in/jaime-valles-2a1728221/My substack FREE: https://substack.com/@dansfera1?r=27gh4e&utm_medium=ios&utm_source=profileInato: https://go.inato.com/3VnSro6CRIO: http://www.clinicalresearch.ioMy PatientACE recruitment company: https://patientace.com/Join me at my conference! http://www.saveoursites.comText Me: (949) 415-6256Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7aGET THE BOOK! https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1?keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorrText "guru" to 855-942-5288 to join VIP list!My blog: http://www.TheClinicalTrialsGuru.comMy CRO and Site Network: http://www.DSCScro.comMy CRA Academy: http://www.TheCRAacademy.comMy CRC Academy: http://www.TheCRCacademy.comLatinos In Clinical Research: http://www.LatinosinClinicalResearch.comThe University Of Clinical Research: https://www.theuniversityofclinicalresearch.com/My TikTok: DanSfera

Carla's LinkedIn: https://www.linkedin.com/in/carla-vera-navas-9b5a2439/My substack FREE: https://substack.com/@dansfera1?r=27gh4e&utm_medium=ios&utm_source=profileInato: https://go.inato.com/3VnSro6CRIO: http://www.clinicalresearch.ioMy PatientACE recruitment company: https://patientace.com/Join me at my conference! http://www.saveoursites.comText Me: (949) 415-6256Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7aGET THE BOOK! https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1?keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorrText "guru" to 855-942-5288 to join VIP list!My blog: http://www.TheClinicalTrialsGuru.comMy CRO and Site Network: http://www.DSCScro.comMy CRA Academy: http://www.TheCRAacademy.comMy CRC Academy: http://www.TheCRCacademy.comLatinos In Clinical Research: http://www.LatinosinClinicalResearch.comThe University Of Clinical Research: https://www.theuniversityofclinicalresearch.com/My TikTok: DanSfera

In this episode, host Jeremy Schrand welcomes Tim Schroeder, Founder & CEO of CTI, Jaqueline Aguiar, Managing Director of APAC/LATAM, and Dr. Ludwig Baumann, Global Regulatory Strategist, for an in-depth conversation about the Asia Pacific region's growing impact on clinical research. Together, they explore how population diversity, regulatory innovation, and advanced therapies are shaping the future of clinical trials. The discussion highlights real-world examples, regional strategies, and the evolving role of technology and local expertise in bringing new therapies to patients worldwide.01:33 Welcome to the guests and setting the stage for the discussion.01:50 Key drivers behind Asia Pacific's growth: globalization of research, population scale, rare disease focus, and the need for global market access.03:04 Panelists discuss the region's diversity, infrastructure maturation, and regulatory harmonization efforts (ASEAN guidelines, mutual recognition).05:10 Addressing past concerns about research qualityin Asia Pacific and how they've been resolved.06:15 CTI's strategic expansion into Asia Pacific:doubling of work, global footprint, and real-world examples from COVID-19 vaccine trials in Singapore and Vietnam.08:17 Operational hurdles: regulatory fragmentation, cultural and language diversity, and government investment in science and digital health.10:10 Managing regulatory variability: importance of local expertise, adapting to evolving guidelines, and leveraging relationships with regulators.12:10 Harmonization and efficiency: Singapore's reliance model, Australia's streamlined processes, and their influence as regional role models.14:26 Decentralized and virtual trials post-COVID: remote monitoring, reasons for choosing Australia (speed, tax credits) vs. China (population, cost).16:07 Executing complex, multi-country trials: pivotal registration studies, remote monitoring, and the importance of experienced investigators.18:05 Readiness for advanced therapies: academic medical centers' preparedness, regulatory interest in cell and gene therapy, and the need for in-depth preparation for combination products.20:27 Regulatory flexibility: pre-meetings with authorities, addressing language barriers, and successful integration of Asia Pacific into global trials.22:01 Talent acquisition and retention: strategies for building consistent, high-quality teams across diverse countries.23:53 Patient recruitment: cultural nuances and ensuring data quality and patient retention.26:09 Looking ahead: the impact of AI, harmonization, and infrastructure development on accelerating clinical trial execution in Asia Pacific.28:13 Recent success story: FDA approval of a rare disease drug with global patient participation, highlighting Asia Pacific's role.29:05 Closing thoughts: Asia Pacific's leadership in innovation, regulatory adaptation, and inclusion of rare patient populations.

Denali's LinkedIn: https://www.linkedin.com/in/denalirose/My substack FREE: https://substack.com/@dansfera1?r=27gh4e&utm_medium=ios&utm_source=profileInato: https://go.inato.com/3VnSro6CRIO: http://www.clinicalresearch.ioMy PatientACE recruitment company: https://patientace.com/Join me at my conference! http://www.saveoursites.comText Me: (949) 415-6256Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7aGET THE BOOK! https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1?keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorrText "guru" to 855-942-5288 to join VIP list!My blog: http://www.TheClinicalTrialsGuru.comMy CRO and Site Network: http://www.DSCScro.comMy CRA Academy: http://www.TheCRAacademy.comMy CRC Academy: http://www.TheCRCacademy.comLatinos In Clinical Research: http://www.LatinosinClinicalResearch.comThe University Of Clinical Research: https://www.theuniversityofclinicalresearch.com/My TikTok: DanSfera

The USDA and HHS just released new Dietary Guidelines for Americans. We dig into the new guidelines with Dr. Leigh Frame, our favorite nutrition scientist, co-host of the pod, and co-director of the Frame-Corr Lab here at George Washington University School of Medicine & Health Sciences. An Associate Professor in the departments of Clinical Research & Leadership and Physician Assistant Studies, Leigh combines nutrition and immunity through translational research, leveraging extensive experience in biomedical research and education. Dr. Frame earned her PhD in Human Nutrition and MHS in Immunology from the Johns Hopkins Bloomberg School of Public Health and graduated with Distinction in Biochemistry from Mary Baldwin College. An expert on Integrative Medicine and the gut microbiome, she's also the Executive Director of the GW Office of Integrative Medicine & Health. ◘ Related Links: New Food Guidelines for Americans, https://realfood.gov/; Harvard Healthy Eating Plate, https://nutritionsource.hsph.harvard.edu/healthy-eating-plate/; Dr. Frame's Nutrition Guide, https://rwc.smhs.gwu.edu/nutrition-guide; Canada's Food Guide, https://food-guide.canada.ca/en/ ◘ Transcript bit.ly/3JoA2mz ◘ This podcast features the song “Follow Your Dreams” (freemusicarchive.org/music/Scott_Ho…ur_Dreams_1918) by Scott Holmes, available under a Creative Commons Attribution-Noncommercial (01https://creativecommons.org/licenses/by-nc/4.0/) license. ◘ Disclaimer: The content and information shared in GW Integrative Medicine is for educational purposes only and should not be taken as medical advice. The views and opinions expressed in GW Integrative Medicine represent the opinions of the host(s) and their guest(s). For medical advice, diagnosis, and/or treatment, please consult a medical professional.

Faisal's LinkedIn: https://www.linkedin.com/in/akhtarfaisal/My substack FREE: https://substack.com/@dansfera1?r=27gh4e&utm_medium=ios&utm_source=profileInato: https://go.inato.com/3VnSro6CRIO: http://www.clinicalresearch.ioMy PatientACE recruitment company: https://patientace.com/Join me at my conference! http://www.saveoursites.comText Me: (949) 415-6256Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7aGET THE BOOK! https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1?keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorrText "guru" to 855-942-5288 to join VIP list!My blog: http://www.TheClinicalTrialsGuru.comMy CRO and Site Network: http://www.DSCScro.comMy CRA Academy: http://www.TheCRAacademy.comMy CRC Academy: http://www.TheCRCacademy.comLatinos In Clinical Research: http://www.LatinosinClinicalResearch.comThe University Of Clinical Research: https://www.theuniversityofclinicalresearch.com/My TikTok: DanSfera

In today's show, the art piece "Tornado Town" is looking for a new space after spending time touring the region, and 40 Arkansas students enrolling at UAMS will have all tuition and fees paid for the length of their program this fall. 

My substack FREE: https://substack.com/@dansfera1?r=27gh4e&utm_medium=ios&utm_source=profileInato: https://go.inato.com/3VnSro6CRIO: http://www.clinicalresearch.ioMy PatientACE recruitment company: https://patientace.com/Join me at my conference! http://www.saveoursites.comText Me: (949) 415-6256Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7aGET THE BOOK! https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1?keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorrText "guru" to 855-942-5288 to join VIP list!My blog: http://www.TheClinicalTrialsGuru.comMy CRO and Site Network: http://www.DSCScro.comMy CRA Academy: http://www.TheCRAacademy.comMy CRC Academy: http://www.TheCRCacademy.comLatinos In Clinical Research: http://www.LatinosinClinicalResearch.comThe University Of Clinical Research: https://www.theuniversityofclinicalresearch.com/My TikTok: DanSfera

Noninterventional studies in clinical research are underutilized in clinical research and inefficient. Dan Drozd, CMO of PicnicHealth, knows we can do better. With host Deborah Borfitz, Drozd discusses the issues and ramifications researchers face from the lack of noninterventional studies, offers tactics for raising the bar for evidence generation, and shares what he expects in the clinical research space in 2026 in this episode of the Scope of Things. Plus, Borfitz shares the latest news on an expanding good pharma score card, an entirely telehealth-based cancer trial, a novel online platform for bowel cancer research, improving patient-reported outcomes in cancer trials, a virtual clinical trial for psychedelics, and identifying Type 1 diabetes in the symptom-less window stage. Show Notes   News Roundup Good Pharma Scorecard Study in JAMA Internal Medicine News on the Yale Scool of Medicine website  Nationwide telehealth trial for cancer News on The Ohio State University website Online platform for bowel cancer research News on the Newcastle University website Patient-reported outcomes in cancer clinical trials Paper in The Lancet Oncology News on the European Organisation for Research and Treatment of Cancer website Virtual clinical trial of psychedelics Research article in Advanced Science Type 1 diabetes risk prediction testing Study in The Lancet News on the University of Exeter website Guest Dan Drozd, M.D., CMO of PicnicHealth The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News senior writer, Deborah Borfitz, welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider's look at clinical research today.

My substack FREE: https://substack.com/@dansfera1?r=27gh4e&utm_medium=ios&utm_source=profileInato: https://go.inato.com/3VnSro6CRIO: http://www.clinicalresearch.ioMy PatientACE recruitment company: https://patientace.com/Join me at my conference! http://www.saveoursites.comText Me: (949) 415-6256Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7aGET THE BOOK! https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1?keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorrText "guru" to 855-942-5288 to join VIP list!My blog: http://www.TheClinicalTrialsGuru.comMy CRO and Site Network: http://www.DSCScro.comMy CRA Academy: http://www.TheCRAacademy.comMy CRC Academy: http://www.TheCRCacademy.comLatinos In Clinical Research: http://www.LatinosinClinicalResearch.comThe University Of Clinical Research: https://www.theuniversityofclinicalresearch.com/My TikTok: DanSfera

Dr. Elena Gross is a neuroscientist, PhD in clinical research and most importantly - a former chronic migraineur. The lack of tolerable and efficacious treatment options for migraine led her to pursue a MSc in Neuroscience at the University of Oxford and a PhD in Clinical Research at the University of Basel, with the goal of having a better understanding of this common and debilitating disease and ultimately improving clinical care. I am particularly passionate about the therapeutic benefits of ketosis and other nutritional interventions, the role of mitochondrial functioning and energy metabolism in brain health & neurological diseases (particularly migraine), as well as increasing our health span via disease prevention. She is the inventor of four patents, founder & CEO of KetoSwiss and Brain Ritual. Her migraine research papers have been published in high-ranking journals. Disclaimer: None of what we talk about is to be considered medical advice, everything is personal experience only. Please discuss with your medical professional before making any changes concerning your health, diet, or products used. Book: How to Master Migraine https://amzn.to/4i34ZN6 Brain Food: www.brainritual.com https://www.brainritual.com/hackmyage $30 off   Contact Dr. Elena Gross: @drelenagross  @brainritual  Email: info@brainritual.com Give thanks to our sponsors: Try Vitali skincare. 20% off with code ZORA here - https://vitaliskincare.com Get Primeadine spermidine by Oxford Healthspan. 15% discount with code ZORA ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ - http://oxfordhealthspan.com/discount/ZORA Get Mitopure Urolithin A by Timeline. 20% discount with code ZORA at https://timeline.com/zora Try Suji to improve muscle 10% off with code ZORA at TrySuji.com - https://trysuji.com Try OneSkin skincare with code ZORA for 15% off https://oneskin.pxf.io/c/3974954/2885171/31050   Join the Hack My Age community on: YouTube: https://youtube.com/@hackmyage Facebook Page: ⁠⁠⁠⁠⁠@⁠Hack My Age⁠     Facebook Group: ⁠⁠⁠⁠⁠⁠@⁠Biohacking Menopause⁠⁠⁠⁠⁠⁠ ⁠   Biohacking Menopause Private Women's Only Support Group: https://hackmyage.com/biohacking-menopause-membership/ Instagram: ⁠⁠⁠⁠⁠@⁠HackMyAge⁠    Website: ⁠⁠⁠⁠⁠⁠HackMyAge.com⁠    For partnership inquiries: https://www.category3.ca/  For transparency: Some episodes of Hack My Age are supported by partners whose products or services may be discussed during the show. The host may receive compensation or earn a minor commission if you purchase through affiliate links at no extra cost to you. All opinions shared are those of the host and guests, based on personal experience and research, and do not necessarily represent the views of any sponsor. Sponsorships do not imply medical endorsement or approval by any healthcare provider featured on this podcast.  

Bipolar depression and mixed episodes remain among the most difficult—and highest-risk—conditions in psychiatry. Even when mood symptoms improve, many patients continue to experience significant cognitive and functional impairment.On NYU Insights on Psychiatry, Dan Iosifescu, MD, explains why standard treatment approaches so often fall short. Dr. Iosifescu argues that symptom suppression is frequently mistaken for recovery, that short-term improvement does not equal durable treatment, and that bipolar mixed episodes expose the limits of one-size-fits-all care.The discussion focuses on the clinical dangers of mixed episodes, the challenge of recognizing them, and the importance of acute stabilization followed by a deliberate transition to sustainable long-term treatment. Dr. Iosifescu also explores how emerging biological research—including metabolic interventions and personalized experimental models—may eventually help clinicians better match patients to treatments.Rather than offering quick fixes, this conversation reframes how clinicians think about success, recovery, and personalization in the treatment of bipolar depression.Guest: Dan Iosifescu, MD, Director of Clinical Research at the Nathan Kline Institute and Director of the Mood Disorders Clinical and Research Program at NYU Langone Health.Watch Insights on Psychiatry on YouTubeSenior Producer: Jon Earle

Send us a textJavonte Maynor joins Dr. Erich Schramm to talk about Mr. Maynor's journey from Division I basketball to starting and running a clinical research site. The entrepreneur talks about his passion for clinical research, representation, and how historically low representation of minorities is a design choice which can be remedied. The duo discusses methods of increasing diversity, trust, and good patient outcomes and how those three ideas are intrinsically linked. They finish the conversation by talking about a shared interest, medical cannabis and the slow movement towards more natural medicines.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Inato: https://go.inato.com/3VnSro6CRIO: http://www.clinicalresearch.ioMy PatientACE recruitment company: https://patientace.com/Join me at my conference! http://www.saveoursites.comText Me: (949) 415-6256Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7aGET THE BOOK! https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1?keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorrText "guru" to 855-942-5288 to join VIP list!My blog: http://www.TheClinicalTrialsGuru.comMy CRO and Site Network: http://www.DSCScro.comMy CRA Academy: http://www.TheCRAacademy.comMy CRC Academy: http://www.TheCRCacademy.comLatinos In Clinical Research: http://www.LatinosinClinicalResearch.comThe University Of Clinical Research: https://www.theuniversityofclinicalresearch.com/My TikTok: DanSfera

Host Mikalyn DeFoor, MD Guest interviewee Matthew T. Provencher, MD, MBA, FAAOS, CAPT, MC, USNR (Ret),discussing his review article, "Advancement in Care Through Applied Translational and Clinical Research in Anterior Shoulder Instability: Military Contribution Over 25 Years: Kappa Delta Award" from the December 1, 2025 issue (https://journals.lww.com/Jaaos/toc/2025/12010) Article summarized from the December 1, 2025 issue (https://journals.lww.com/Jaaos/toc/2025/12010) Review article "2025 Arnold Caplan Award RECLAIM: A Translational Platform for Cartilage Repair and Musculoskeletal Tissue Regeneration Using Allogeneic MSCs" Articles summarized from the December 15, 2025 issue (https://journals.lww.com/Jaaos/toc/2025/12150) Research article "Comparing Fixation Techniques in Metacarpal Fractures: Intramedullary Screw Versus Open Reduction Internal Fixation With Plate and Screw Construct" Follow this link to download these and other articles from the December 1, 2025 issue of JAAOS (https://journals.lww.com/Jaaos/toc/2025/12010) and the December 15, 2025 issue of JAAOS (https://journals.lww.com/Jaaos/toc/2025/12150). The JAAOS Unplugged podcast series is brought to you by the Journal of the American Academy of Orthopaedic Surgeons and the AAOS Resident Assembly.

Inato: https://go.inato.com/3VnSro6CRIO: http://www.clinicalresearch.ioMy PatientACE recruitment company: https://patientace.com/Join me at my conference! http://www.saveoursites.comText Me: (949) 415-6256Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7aGET THE BOOK! https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1?keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorrText "guru" to 855-942-5288 to join VIP list!My blog: http://www.TheClinicalTrialsGuru.comMy CRO and Site Network: http://www.DSCScro.comMy CRA Academy: http://www.TheCRAacademy.comMy CRC Academy: http://www.TheCRCacademy.comLatinos In Clinical Research: http://www.LatinosinClinicalResearch.comThe University Of Clinical Research: https://www.theuniversityofclinicalresearch.com/My TikTok: DanSfera

In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable is joined by Dr. Doug Thamm, Stuart Presidential Chair in Oncology and Director of Clinical Research at the Colorado State University Flint Animal Cancer Center. Dr. Thamm discusses how naturally occurring cancers in dogs are advancing cancer drug development and informing treatment strategies in both veterinary and human medicine. He shares real-world examples of comparative oncology in action and the role clinical trials play in bringing new therapies to patients. The conversation also explores the challenges of oncology drug development, regulatory pathways, and emerging areas such as biologics, genomic sequencing, and AI-driven tools—offering a clear-eyed view of where veterinary oncology is headed.

Founder Lulu Ge turned personal pain into purpose with Elix, an herbal wellness brand rooted in Chinese medicine with 90% repeat customers.For more on Elix and show notes click here Subscribe and watch Shopify Masters on YouTube!Sign up for your FREE Shopify Trial here.

Inato: https://go.inato.com/3VnSro6CRIO: http://www.clinicalresearch.ioMy PatientACE recruitment company: https://patientace.com/Join me at my conference! http://www.saveoursites.comText Me: (949) 415-6256Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7aGET THE BOOK! https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1?keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorrText "guru" to 855-942-5288 to join VIP list!My blog: http://www.TheClinicalTrialsGuru.comMy CRO and Site Network: http://www.DSCScro.comMy CRA Academy: http://www.TheCRAacademy.comMy CRC Academy: http://www.TheCRCacademy.comLatinos In Clinical Research: http://www.LatinosinClinicalResearch.comThe University Of Clinical Research: https://www.theuniversityofclinicalresearch.com/My TikTok: DanSfera

In this episode, Carsten Bick shares his path from building healthcare services businesses to leading PhaseWell Research. He reflects on what drew him to clinical research, the opportunity to expand patient and physician access in a fragmented industry, and why people remain central to creating a successful platform. Carsten discusses scaling clinical trials through thoughtful partnerships, why culture and trust matter as much as process and technology, and how Shore Capital's people-first approach aligned with his vision for long-term growth. He underscores the responsibility of building alongside experienced founders, staying close to patients, and letting purpose guide PhaseWell's strategy and leadership.Key Takeaways:People-first leadership comes first, shaping how teams are built, decisions are made, and care is delivered throughout the organization.Expanding access to clinical research requires engaging more physicians and patients in a highly fragmented industry.Trust, culture, and experienced partnerships enable growth while preserving quality, integrity, and alignment with mission.Long-term success is driven by staying close to purpose, investing in people, and building platforms alongside partners who share a long-term vision.Chapters:00:00 - Introduction05:57 - Expanding Access in a Fragmented Industry17:17 - People-First Leadership20:27 - Building Trust Through the Right Partnerships24:57 - Purpose, Scale, and Long-Term GrowthListen to our podcasts at:https://www.shorecp.university/podcastsYou'll also find other Microcap Moments episodes, alongside our series Everyday Heroes and Bigger. Stronger. Faster., highlighting the people and stories that make the microcap space unique.Other ways to connect:Blog: https://www.shorecp.university/blogShore University: https://www.shorecp.university/Shore Capital Partners: https://www.shorecp.com/LinkedIn: https://www.linkedin.com/company/shore-universityThis podcast is the property of Shore Capital Partners LLC. None of the content herein is investment advice, an offer of investment advisory services, or a recommendation or offer relating to any security. See the “Terms of Use” page on the Shore Capital website for other important information.

In this episode, Carsten Bick shares his path from building healthcare services businesses to leading PhaseWell Research. He reflects on what drew him to clinical research, the opportunity to expand patient and physician access in a fragmented industry, and why people remain central to creating a successful platform. Carsten discusses scaling clinical trials through thoughtful partnerships, why culture and trust matter as much as process and technology, and how Shore Capital's people-first approach aligned with his vision for long-term growth. He underscores the responsibility of building alongside experienced founders, staying close to patients, and letting purpose guide PhaseWell's strategy and leadership.Key Takeaways:People-first leadership comes first, shaping how teams are built, decisions are made, and care is delivered throughout the organization.Expanding access to clinical research requires engaging more physicians and patients in a highly fragmented industry.Trust, culture, and experienced partnerships enable growth while preserving quality, integrity, and alignment with mission.Long-term success is driven by staying close to purpose, investing in people, and building platforms alongside partners who share a long-term vision.Chapters:00:00 - Introduction05:57 - Expanding Access in a Fragmented Industry17:17 - People-First Leadership20:27 - Building Trust Through the Right Partnerships24:57 - Purpose, Scale, and Long-Term GrowthListen to our podcasts at:https://www.shorecp.university/podcastsYou'll also find other Microcap Moments episodes, alongside our series Everyday Heroes and Bigger. Stronger. Faster., highlighting the people and stories that make the microcap space unique.Other ways to connect:Blog: https://www.shorecp.university/blogShore University: https://www.shorecp.university/Shore Capital Partners: https://www.shorecp.com/LinkedIn: https://www.linkedin.com/company/shore-universityThis podcast is the property of Shore Capital Partners LLC. None of the content herein is investment advice, an offer of investment advisory services, or a recommendation or offer relating to any security. See the “Terms of Use” page on the Shore Capital website for other important information.

The Big Unlock · Gregory Goldmacher, M.D., Associate Vice President in Clinical Research, and Head of Clinical Imaging & Pathology, Merck Research Laboratories In this episode, Dr. Greg Goldmacher, Associate VP of Clinical Research at Merck, known as MSD outside of the United States and Canada, explains how AI is transforming imaging, clinical trials, and early-stage drug development. Greg describes endpoints as the core of every clinical trial, since they determine whether a therapy is safe or effective. He notes that AI is not new to imaging and aligns well with pattern recognition, yet its real value lies in identifying details that humans often miss. Greg stresses that drug development still depends on huge volumes of data spread across legacy systems. Without strong data standardization, AI cannot deliver reliable results. He also points to the FDA's evolving guidance on AI and emphasizes the need for rigorous validation before using AI-derived measurements for regulatory decisions. Greg highlights the opportunity to improve efficiency, reduce human burden, and generate more consistent insights. With thoughtful adoption, AI can support better decisions in clinical development and improve outcomes for patients. Take a listen.

Explore how residents balance the operating room with clinical research. This episode covers why research matters, how to start, and how it enhances evidence-based practice.Host: Aleksandar Jovanović, MD (Serbia)Guests:Lynn Jeffers, MD, MBA, FACSJustin M. Sacks MD MBA FACSHelen Xun, MD

Show Links:https://pendulumlife.com/How Insulin WorksChapters 00:00 Understanding the Microbiome and Its Impact on Health12:05 The Role of Acromansia in Gut Health30:13 Clinical Insights and Research on Probiotics44:15 Addressing Autoimmunity and Metabolic Health56:27 Practical Applications and Recommendations for Probiotics  To learn more about Mission 22's impact and programs, visit www.mission22.org or find us on social media. IG: @mission_22. Tiktok: @_mission22

On this Make A Difference Minute, Catharine Grimes, President of the Bristol Myers Squibb Foundation, shares how the Foundation's investment in the Winn Awards program has grown into a national effort to expand access to clinical research, build trust in communities, and improve health outcomes for patients across the country. Sponsor: CoraNation Tailoring & Alterations

We kicked off the program with four news stories and different guests on the stories we think you need to know about! 70th Anniversary of Globe Santa! What the program does each year for thousands of children.Guest: Linda Matchan – Boston Globe correspondent - the writer and editor for Globe Santa Big Brothers Big Sisters of Central Mass & Metrowest hit a big milestone this year making more new matches so far this school year than in the previous 10 years (180 matches)! What makes the program so important.Guest: Connie Askin - CEO of Big Brothers Big Sisters of Central Mass & MetroWest American Lung Association Urges Flu Vaccination Following Most Severe Flu Season in Over a DecadeGuest: Dr. David Hill – Pulmonologist, Director of Clinical Research at Waterbury Pulmonary Associates and Volunteer Medical Spokesperson for the American Lung Association CDC drops newborn Hepatitis B recommendation, leaving parents with conflicting guidance…Guest: Charles Hannum, MD, General Pediatrician at Tufts Medical Center See omnystudio.com/listener for privacy information.

Feeling tired and washed out? It could be more than fatigue. Lori Hartwell and Dr. Todd Minga, Vice-President of Clinical Research and Medical Affairs at Akebia Therapeutics uncover how anemia and kidney disease intertwine"and why understanding this hidden link could change how you manage your health.

Kurt Bramer from Advanced CPR Solutions comes back for a final look at Head-Up CPR as we pull all the pieces from the earlier four episodes together. Dr. Joe Holley is back to bring in the latest research into the process as well. We will tie all this back to the global health disaster that is sudden cardiac arrest. Recent research from across the emergency medical community has pointed to impressive improvements in both return of spontaneous circulation (ROSC) as well as survival to discharge and neurologically intact survival when compared to conventional supine CPR performance. We’ll have links below to some of those studies and papers. Research Bibliography for Head-Up CPR Studies The episode is co-hosted again by our regular hosts, Sam Bradley and Jamie Davis. Elevated CPR Series Episode One Elevated CPR Series Episode Two Elevated CPR Series Episode Three Elevated CPR Series Episode Four CARES Registry for Cardiac Arrest Stats Follow up on more of these segments as we continue to look at the current research trends in future episodes and what is on the horizon for the future. The episode was co-hosted by Sam Bradley and Jamie Davis. Scroll down for Podcast Discussion Summary Thank you as always to Paragon Medical Education Group for their long-term support of the Disaster Podcast. Dr. Joe Holley and the team at Paragon continue to provide excellent and customized disaster response training to jurisdictions around the U.S. and internationally as well. Podcast Discussion Summary Head-Up CPR Research Update Jamie and Sam discussed the upcoming podcast episode, which will focus on wrapping up the last four episodes about head-up CPR and recent research. They mentioned the challenges of implementing new approaches in rural systems with volunteer staff. Sam noted that Dr. Joe and Kurt Bramer have been working on presenting the information in a way that can be applied responsibly. Joe briefly mentioned that SENA teams were activated to assist with floods in Seattle. The main focus of the episode will be on the latest data on head-up CPR, including improved physiology, survival rates, and neurological function, particularly for non-shockable rhythms like asystole. Advantages of Head-Up CPR Studies Sam, Kurt, and Joe discussed the significance of two seminal studies on head-up CPR. The 2016 preclinical animal study showed significant improvement in perfusion when compared to standard CPR, with a synergistic effect when using additional devices like the ITD and suction cup. The 2022 independent registry analysis demonstrated that head-up CPR resulted in a five times greater likelihood of neurologically intact survival compared to conventional CPR, even up to 20 minutes post-cardiac arrest. Joe explained that the bundled care approach for cardiac arrest patients involves multiple components, including appropriate ventilation, high-quality CPR, and post-resuscitation care, all of which contribute to improved outcomes. Bystander CPR System Implementation The discussion focused on the importance of proper implementation of bystander CPR, AEDs, and advanced techniques like impedance threshold devices and suction cup CPR to improve patient outcomes, particularly neurologic ones. Kurt emphasized the need for a system-wide approach, from first responders to hospital care, highlighting successful partnerships like Louisville’s, where continuity of care is prioritized. Jamie inquired about best practices for implementing this system-wide approach, to which Kurt responded with examples from different regions, noting that while ideal partnerships exist, proactive agencies can still achieve good outcomes even with less supportive hospitals. Cardiac Arrest Resuscitation Bundle Implementation The team discussed the importance of addressing multiple aspects of cardiac arrest resuscitation simultaneously, as highlighted by Joe, who emphasized that successful outcomes require implementing all elements of the care bundle equally. Jamie inquired about training approaches, to which Joe responded that effective training involves both initial instruction and ongoing feedback through quality improvement processes, stressing that successful resuscitations require adherence to the entire bundle rather than just some components. Prioritizing Tasks in Resuscitation Joe and Kurt discussed the importance of prioritizing tasks during resuscitation, emphasizing the need to focus on the overall process rather than individual steps. They highlighted the benefits of the Head-Up CPR model, which organizes priorities and reduces chaos during medical emergencies. Kurt explained that this method allows for more efficient and coordinated delivery of therapies, leading to better patient outcomes. Head-Up CPR Survival Benefits The group discussed two significant studies on CPR techniques. Kurt presented findings from a 2023 preclinical study showing that early administration of head-up CPR resulted in a 40% 24-hour survival rate compared to 9% for delayed conventional CPR. Joe highlighted an observational study from 2024 showing that head-up CPR improved survival rates for non-shockable rhythms from 2.8% to 7.6%, representing a nearly 3-fold improvement. Both studies suggested that head-up CPR could significantly enhance survival chances, particularly when administered early. Non-Perfusible Rhythm Blood Flow Method The group discussed a new methodology for perfusing patients with non-perfusible rhythms, which allows for continued blood flow and preserves neurological status. Joe explained that this could open up windows for interventions like ECMO or cardiac catheterization while CPR is underway. Kurt shared anecdotal evidence from agencies that have gained confidence in staying longer during arrests, leading to increased rates of ROSC in non-shockable rhythms. The group also touched on the importance of proper ventilation during CPR, with Joe highlighting the lack of focus on this aspect in many clinical trials. Head-Up CPR Survival Benefits Joe explained the concept of pressure-volume loops in CPR, demonstrating that head-up CPR generates greater blood flow and pressures compared to standard CPR. Kurt presented data from two studies comparing outcomes between CARES and head-up CPR data, showing improved survival rates for head-up CPR patients over one and five-year periods. The research suggests that head-up CPR may lead to better patient outcomes, though these findings were not included in the 2025 American Heart Association guidelines. Cardiac Arrest Economic Impact Discussion The group discussed the economic impact of cardiac arrests, with Kurt noting that the total cost per person in the US is approximately $4,000 annually, highlighting the need for improved resuscitation techniques. Jamie emphasized the importance of community contributions from survivors, while Joe provided recommendations for enhancing CPR quality, including the use of the Lucas 3.1 device with its enhanced lift feature and avoiding overly tight cervical collars during CPR to maintain blood flow. Improving Sudden Cardiac Arrest Response The meeting focused on sudden cardiac arrest, emphasizing its global impact as a leading cause of death. Kurt and Joe discussed the need for first response agencies and emergency managers to explore research and improve care delivery to enhance patient survivability. Joe highlighted the importance of understanding the physiology of cardiac arrest and considering new approaches, as current CPR methods have not changed in 50 years. Jamie suggested applying disaster management strategies to sudden cardiac arrest to improve outcomes. Joe mentioned upcoming procedural cadaver labs and ongoing work on superglottic studies and new airway management tools. Kurt provided contact information for further discussions and was invited to return for future updates on research. Podcast Series Conclusion and Future Plans The group discussed the conclusion of a podcast series on medical topics, with Kurt expressing gratitude for the opportunity to share his message and Jamie inviting him back for future episodes. They agreed to continue the conversation on social media and the Disaster Podcast website, with Kurt planning to draft questions for potential CEU credits. The group the role of specialized training, with Jamie highlighting the sponsorship of the Disaster Podcast by Paragon Medical Education Group. Catch the full episode using the player above or on your favorite podcast platform, and don't forget to subscribe to the Disaster Podcast for weekly insights from leaders in disaster response and research!

In this episode, Dr. Zanotti discusses the role of Procalcitonin in the ICU. He is joined by Dr. Simran Gupta, an infectious disease specialist at Brigham & Women's Hospital in Boston. Dr. Gupta has additional training in Clinical Research, Transplant, and Infectious Disease. She recently published an article on reassessing the role of Procalcitonin in critically ill patients with sepsis. Additional resources: Reassessing Procalcitonin-Guided Antibiotic Therapy in Critically Ill Patients with Sepsis: Lessons from the ADAPT-Sepsis Trial. S. Gupta, et al. Clinical Infectious Disease 2025: https://pubmed.ncbi.nlm.nih.gov/40579227/ Biomarker-Guided Antibiotic Duration for Hospitalized Patients With Suspected Sepsis: The ADAPT-Sepsis Randomized Clinical Trial. JAMA 2025: https://pubmed.ncbi.nlm.nih.gov/39652885/ Procalcitonin-guided antibiotic therapy may shorten the length of treatment and may improve survival- a systematic review and meta-analysis. M Papp, et al. Crit Care 2023: https://pubmed.ncbi.nlm.nih.gov/37833778/ Books and entertainment mentioned in this episode: Shantaram: A Novel. By Gregory David Roberts: https://bit.ly/4ovVHKX SHANTARAM – Apple TV series: https://tv.apple.com/us/show/shantaram/umc.cmc.atxsrive40xli3zh3uxjimut

Inato: https://go.inato.com/3VnSro6CRIO: http://www.clinicalresearch.ioMy PatientACE recruitment company: https://patientace.com/Join me at my conference! http://www.saveoursites.comText Me: (949) 415-6256Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7aGET THE BOOK! https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1?keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorrText "guru" to 855-942-5288 to join VIP list!My blog: http://www.TheClinicalTrialsGuru.comMy CRO and Site Network: http://www.DSCScro.comMy CRA Academy: http://www.TheCRAacademy.comMy CRC Academy: http://www.TheCRCacademy.comLatinos In Clinical Research: http://www.LatinosinClinicalResearch.comThe University Of Clinical Research: https://www.theuniversityofclinicalresearch.com/My TikTok: DanSfera

Dr. Ralf Jeutter discusses the foundational principles of Hahnemannian homeopathy. He emphasizes the importance of observing patients' unique experiences and symptoms, rather than categorizing diseases or personalities, highlighting Hahnemann's focus on phenomenology. Dr. Jeutter also explores common misconceptions in interpreting the Organon, particularly around mental and emotional symptoms, and stresses that remedies should be understood through careful study of provings and original texts. He cautions against oversimplifying remedies into psychological types, which can obscure the depth of each patient's experience. Throughout the conversation, he encourages a return to the core principles of homeopathy, combining attentive clinical observation with a thorough understanding of the remedies. Episode Highlights: 03:56 - Ralf's Journey into Homeopathy 09:45 - Accessing German Texts and the Organon 11:17 - Misconceptions in Interpreting the Organon 18:00 - What are we supposed to do in a homeopathic consultation 19:33 - Understanding the Altered State in Homeopathy 24:06 - Differences Between Hahnemannian and Kentian Homeopathy 28:59 - The Role of Mental Symptoms 30:17 - The Balance Between Psychological and Physical Symptoms 33:34 - What Truly Never Changed in Hahnemann's Homeopathy 41:43 - A Radical Shift in How We Understand Disease 49:57 - Re-examining the Syphilis Model 57:12 - When Everything Is Called Homeopathy 01:02:59 - Why Studying Hahnemann Still Matters 01:08:22 - Where Did Succussion Really Come From About my Guests: Dr. Ralf Jeutter has been involved in homeopathy for over 20 years and is an international teacher and practitioner. He qualified in homeopathy in 2000 from the North-West College of Homeopathy in the UK and continued his medical and homeopathic training at the Institute of Clinical Research in Bombay and Pune, India. He is medically trained in Podiatric Medicine and holds a Ph.D. in Literature and Philosophy. Dr. Jeutter is a former Director of the Society of Homeopaths, the largest homeopathic membership organisation in the UK. Dr. Jeutter is Head of Academic Affairs and Head of Philosophy at the Centre for Homeopathic Education (CHE) in New York and teaches homeopathy internationally, including in London, Budapest, and New York. For over 10 years, he has been involved in the Materia Medica Pura Project initiated and led by Dr. André Saine. His professional focus is on Hahnemannian homeopathy, comparative materia medica, repertory work, and a solid understanding of the foundations and philosophy of Hahnemann and his followers. To learn more about his masterclass on male health issues https://www.cheonline.co.uk/male-health-issues To learn more of his provings https://hpathy.com/ If you would like to support the Homeopathy Hangout Podcast, please consider making a donation by visiting www.EugenieKruger.com and click the DONATE button at the top of the site. Every donation about $10 will receive a shout-out on a future episode. Join my Homeopathy Hangout Podcast Facebook community here: https://www.facebook.com/groups/HelloHomies Follow me on Instagram https://www.instagram.com/eugeniekrugerhomeopathy/ Here is the link to my free 30-minute Homeopathy@Home online course: https://www.youtube.com/watch?v=vqBUpxO4pZQ&t=438s Upon completion of the course - and if you live in Australia - you can join my Facebook group for free acute advice (you'll need to answer a couple of questions about the course upon request to join): www.facebook.com/groups/eughom

Send us a textDr. Sara Collins joins Dr. Michael Koren to talk about her journey as a research cardiologist. They discuss Dr. Collins's path through preparatory school, college, med school, and the post-school experience as a cardiologist. They also discuss her role starting a clinical research site in Washington, D.C., and her efforts to leverage the research apparatus to provide equitable care to otherwise disadvantaged and underserved communities. Dr. Collins talks about how there is a racial disconnect in care in spite of the typically good insurance coverage in the D.C. area.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Inato: https://go.inato.com/3VnSro6CRIO: http://www.clinicalresearch.ioMy PatientACE recruitment company: https://patientace.com/Join me at my conference! http://www.saveoursites.comText Me: (949) 415-6256Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7aGET THE BOOK! https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1?keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorrText "guru" to 855-942-5288 to join VIP list!My blog: http://www.TheClinicalTrialsGuru.comMy CRO and Site Network: http://www.DSCScro.comMy CRA Academy: http://www.TheCRAacademy.comMy CRC Academy: http://www.TheCRCacademy.comLatinos In Clinical Research: http://www.LatinosinClinicalResearch.comThe University Of Clinical Research: https://www.theuniversityofclinicalresearch.com/My TikTok: DanSfera

In today's episode, we had the pleasure of speaking with Shubham Pant, MD, MBBS, about the first-line treatment of patients with metastatic pancreatic cancer. Dr Pant is a professor in the Department of Gastrointestinal (GI) Medical Oncology of the Division of Cancer Medicine, director of Clinical Research, and a professor in the Department of Investigational Cancer Therapeutics at The University of Texas MD Anderson Cancer Center in Houston. In our exclusive interview, Dr Pant discussed factors that drive frontline chemotherapy selection for metastatic pancreatic cancer, the role of NALIRIFOX (irinotecan liposome [Onivyde], oxaliplatin, 5-fluorouracil, and leucovorin) in this treatment setting, and how the first-line treatment paradigm may evolve and expand going forward.

Welcome to OncLive On Air®! OncLive On Air is a podcast from OncLive®, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions. In today's episode, we had the pleasure of speaking with Cassie Kline, MD, MAS, about updated efficacy data from the phase 2 FIREFLY-1 study (NCT04775485) of tovorafenib (Ojemda) in patients with relapsed/refractory pediatric low-grade glioma (pLGG) that were presented at the 2025 Society of Neuro-Oncology Annual Meeting. Dr Kline is an attending physician and director of Clinical Research in the Department of Neuro-Oncology at Children's Hospital of Philadelphia in Pennsylvania. In our exclusive interview, Dr Kline discussed longer-term efficacy and safety data from the trial, noting the sustained response rates, continued tumor shrinkage, and rates of patients who remained treatment free after approximately 36 months of follow-up. _____ That's all we have for today! Thank you for listening to this episode of OncLive On Air. Check back throughout the week for exclusive interviews with leading experts in the oncology field. For more updates in oncology, be sure to visit www.OncLive.com and sign up for our e-newsletters. OncLive is also on social media. On X and BlueSky, follow us at @OncLive. On Facebook, like us at OncLive, and follow our OncLive page on LinkedIn. If you liked today's episode of OncLive On Air, please consider subscribing to our podcast on Apple Podcasts, Spotify, and many of your other favorite podcast platforms,* so you get a notification every time a new episode is posted. While you are there, please take a moment to rate us! Thanks again for listening to OncLive On Air. *OncLive On Air is available on: Apple Podcasts, Spotify, CastBox, Podcast Addict, Podchaser, RadioPublic, and TuneIn. This content is a production of OncLive; this OncLive On Air podcast episode is supported by funding, however, content is produced and independently developed by OncLive.

Send us a textDr. Michael Koren joins Kevin Geddings to give thanks this week. The doctor gives gratitude to Kevin, his team, clinical research staff, MedEvidence staff, and most of all, patients. Dr. Koren expresses his heartfelt thanks to everyone who pushes science and research forward!Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textJoin us as we explore the fascinating topographies that play a crucial role in enhancing myopia management success.Randy Kojima, with years of experience and a wealth of knowledge, guides us through the intricate landscapes of myopia management strategies. From innovative technologies to strategic interventions, we uncover the topographical nuances that can make a significant impact on effectively managing myopia.Discover the latest advancements in myopia research and gain valuable insights into the importance of personalized approaches. Randy shares real-world case studies and success stories, shedding light on how topographies have transformed the landscape of myopia management for both practitioners and patients alike.Whether you're a seasoned optometrist, a curious researcher, or someone affected by myopia, this episode provides a comprehensive exploration of the tools and techniques that contribute to successful myopia management outcomes.Tune in as we navigate through the multifaceted terrains of myopia management with Randy Kojima, unraveling the complexities and discovering the topographical keys to achieving success in the field. Don't miss this insightful conversation on The Myopia Podcast!About Randy Kojima:Randy Kojima is the Clinical Research and Development Director for Precision Technology based in Vancouver, Canada. He also serves as Research Scientist and Clinical Instructor at the Pacific University College of Optometry in Forest Grove, Oregon. Additionally, he is a clinical advisor to Medmont Instruments in Melbourne, Australia.Randy has published numerous articles and submitted posters on various contact lens related topics as well as been a contributing author in a number of text book chapters. He lectures globally and enjoys sharing insights, methods and research with eye care colleagues from around the world.Randy is a Fellow of the American Academy of Optometry, the British Contact Lens Association, the Scleral Lens Education Society and the International Academy of Orthokeratology.Review for Myopia Management: https://reviewofmm.com/------If you're considering or have ever considered getting a virtual team member for your practice check out hiredteem.com, mention The Myopia Podcast when signing up for a $250 dollar discount off of your first month's teem member.https://hireteem.com/myopia-podcast/

  Fertility Docs Uncensored is hosted by Dr. Carrie Bedient from the Fertility Center of Las Vegas, Dr. Susan Hudson from Texas Fertility Center, and Dr. Abby Eblen from Nashville Fertility Center. Today, they had a special Guest: Phillip Romanski, Associate Research Director of US Fertility. He is also an Assistant Professor and Associate Program Director of the reproductive endocrinology fellowship at Mount Sinai. In this episode, the docs explore how research shapes the future of fertility care. As Associate Research Director for US Fertility, Dr. Romanski shares how the organization leverages its extensive national data to support studies that directly influence patient outcomes. With eight to nine active clinical studies, patients can visit the US Fertility website to learn about current opportunities to participate, helping advance science, even if the immediate benefits are for future patients. Dr. Romanski highlights a recent study examining development in embryos that initially appeared to have abnormal fertilization. Surprisingly, many of these embryos progressed to the blastocyst stage, and a significant number were genetically normal. This information may help increase the number of viable embryos for future transfer. He also discusses a recent study with unexpected results: a comparison of fertilization outcomes between ICSI and conventional insemination with frozen sperm. Traditionally, eggs are fertilized with ICSI when using frozen sperm. By dividing eggs from individual patients and comparing ICSI with conventional insemination, the team found no difference in fertilization outcomes. This finding could reduce unnecessary embryo manipulation, minimize risk, and decrease costs for patients. This episode takes a fascinating look at how research today is improving the fertility treatments of tomorrow. This podcast was sponsored by US Fertility. 

“Study” that's not even a study spreads panic about dubious melatonin-heart failure link; Should you ignore dr's advice to take powerful acid-blocking drugs? Novel implantable electrical pacemakers may bring relief to sufferers of severe constipation; Benefits of cocoa flavanols for heart, brain, athletic performance. Give the gift of healthy chocolate! Go to FlavaNaturals.com and use coupon code HOFFMAN20 for 20% off site-wide. Plus get free shipping on all orders over $30. 

Just 4 simple lifestyle measures deliver 9 additional years of disease-free healthspan; Study underscores protein's role in staving off cancer, heart disease, and death; CoQ10 scores vs. neurodegeneration; Urolithin A (Mitopure®️) found to support athletic performance, immune function; Why you should ignore some influencers' advice to avoid fish oil. 

Daylight Savings Time changeover health myths busted; A doctor breaks her ankle and is billed $64,000 in uncovered expenses; Vitamin D shields life-prolonging telomeres, may help depression; The vaunted DASH Diet for hypertension faces off against low-carb alternative; The critical first 1000 days after conception—early life sugar avoidance yields major later life health dividends; Do you really need hot water to disinfect your hands?